Introduction: Immunosenescence contributes to the development of auto-antibodies. However, while the prevalence of some autoantibodies increases with age, the incidence of connective tissue diseases decreases with age. This study aims to determine the clinical and paraclinical characteristics of connective tissue diseases in the elderly population. Materials and Methods: We conducted a retrospective and descriptive study, from March 2010 to March 2021, in the Internal Medicine Department of Aristide Le Dantec Hospital, including all the medical records of patients followed up for connective tissue disease and whose symptomatology began at an age greater than or equal to 65 years. Epidemiological, clinical, paraclinical, therapeutic and evolutionary data were collected from a pre-established survey form and then processed using SPSS software. Results: Overall, 22 cases were collected out of 275 seen on consultation. They involved 16 women and 6 men, aged between 65 and 85 years with a median of 70 years. The mean duration of the clinical picture was 15.7 months with extremes of 1 and 96 months. The clinical symptoms were joint pain in 21 patients associated with dry eye and mouth syndrome in seven cases and one patient underwent isolated dry eye and mouth syndrome. Joint involvement was deforming in 13 patients. Poor general condition was noted in 20 patients. Biology showed anemia in 14 patients, hyperleukocytosis (2 patients) and thrombocytosis (5 patients). The sedimentation rate (SR) was accelerated in 9 patients and the C-reactive protein (CRP) was positive in 12 patients. Immunology showed a positive Latex test (3 patients/6), Waaler-Rose reaction (8 patients/13), anti-cyclic citrullinated peptides (anti-CCP) antibodies (11 patients/11), anti-nuclear antibodies (2 patients/4). Anti-extractable nuclear antigens (anti-ENA) antibody testing in 4 patients showed positive anti-U1RNP (1 case), anti-SSA and anti-SSB (1 case). Plain X-Rays of the hands, wrists and feet showed destructive lesions in 16 patients. The diagnosis of rheumatoid arthritis (RA) was set in 21 patients, one of which was associated with Sjogren’s syndrome (SS) and one with primary Sjogren’s syndrome. Treatment was based on prednisone (21 cases), methotrexate (17 patients), and hydroxychloroquine (9 patients). The evolution was remarkable in 10 patients. Conclusion: Autoimmune diseases in the elderly are uncommon compared to the young adult population. In our study, we only found cases of rheumatoid arthritis and
References
[1]
Hurme, M., Korkki, S., Lehtimäki, T., Karhunen, P.J., Jylhä, M., Hervonen, A., et al. (2007) Autoimmunity and Longevity: Presence of Antinuclear Antibodies Is Not Associated with the Rate of Inflammation or Mortality in Nanogenarians. Mechanisms of Ageing and Development, 128, 407-408. https://doi.org/10.1016/j.mad.2007.03.001
[2]
Dubost, J.J., Pereira, B., Mathieu, S., Tournadre, A., Malochet Guinamand, S., Couderc, M., et al. (2014) Répartition des rhumatismes du sujet agé: Enquête auprès des rhumatologues de la région Auvergne. Revue du Rhumatisme, 81, 69-73. https://doi.org/10.1016/j.rhum.2013.04.011
[3]
Dubost, J.J. and Sauvezie, B. (1992) Current Aspects of Inflammatory Rheumatic Diseases in Elderly Patients. Revue du rhumatisme et des maladies osteo-articulaires, 59, 37S-42S. https://doi.org/10.1016/S0307-742X(21)00618-4
[4]
Stevens, M.B. (1986) Connective Tissue Disease in the Elderly. Clinics in Rheumatic Diseases, 12, 11-32.
[5]
Diallo, S., Niasse, M. and Guèye, Y.A.N. (2020) Connectivites du sujet agé: étude de 74 observations. Revue du Rhumatisme, 87, A253. https://doi.org/10.1016/j.rhum.2020.10.454
[6]
Olivieri, I., Palazzi, C., Peruz, G. and Padula, A. (2005) Management Issues with Elderly-Onset Rheumatoid Arthritis: An Update. Drugs & Aging, 22, 809-822. https://doi.org/10.2165/00002512-200522100-00002
[7]
Daien, C., Hua, C., Gaujoux-Viala, C., Cantagrel, A., Dubremetz, M., Dougados, M., et al. (2019) Update of French Society for Rheumatology Recommendations for Managing Rheumatoid Arthritis. Joint Bone Spine, 86, 135-150. https://doi.org/10.1016/j.jbspin.2018.10.002
[8]
Soubrier, M., Mathieu, S., Payet, S., Dubost, J.J. and Ristori, J.M. (2010) Elderly Onset-Rheumatoid Arthritis. Joint Bone Spine, 77, 290-296. https://doi.org/10.1016/j.jbspin.2010.04.004
[9]
Chiba, H., Matsushita, K., Shibakawa, A. and Aoki, H. (2003) Rheumatoid Arthritis in Patients Aged above 75-Years-Old at Onset. Ryumachi, 43, 557-563. https://doi.org/10.1191/096120399678847353
[10]
García-Carrasco, M., Cervera, R., Rosas, J., Ramos-Casals, M., Ramos-Casals, M., Morlà, R.M., Sisó, A., et al. (1999) Primary Sjögren’s Syndrome in the Elderly: Clinical and Immunological Characteristics. Lupus, 8, 20-23. https://doi.org/10.1007/s00393-009-0518-3
[11]
Westhoff, G. and Zink, A. (2010) Epidemiology of Primary Sjögren’s Syndrome. Zeitschrift für Rheumatologie, 69, 41-49. https://doi.org/10.11604/pamj.2015.20.8.5042
[12]
Chebbi, W., Ben Salem, W., Klii, R., Kessomtini, W., Jerbi, S., Habib Sfar, M. (2015) Syndrome de Gougerot-Sjögren primitif du sujet agé: Caractéristiques cliniques et immunologiques. Pan African Medical Journal, 20, Article No. 8.
[13]
Catoggio, L.J., Skinner, R.P., Smith, G. and Maddison, P.J. (1984) Systemic Lupus Erythematosus in the Elderly: Clinical and Serological Characteristics. The Journal of Rheumatology, 11, 175-181.
[14]
Bell, D.A. (1998) SLE in the Elderly. Is It Really SLE or Systemic Sjögren’s Syndrome? The Journal of Rheumatology, 15, 723-724.
[15]
Rovensky, J. and Tuchynová, A. (2008) Systemic Lupus Erythematosus in the Elderly. Autoimmunity Reviews, 7, 235-239. https://doi.org/10.1016/j.autrev.2007.11.014
[16]
Lazaro, D. (2007) Elderly-Onset Systemic Lupus Erythematosus: Prevalence, Clinical Course and Treatment. Drugs & Aging, 24, 701-715. https://doi.org/10.2165/00002512-200724090-00001
[17]
Spinel-Bejarano, N., Quintana, G., Heredia, R., et al. (2013) Comparative Study of Elderly-Onset Rheumatoid Arthritis and Young-Onset Rheumatoid Arthritis in a Colombian Population: Clinical Laboratory and HLA DRB1 Findings. Clinical and Experimental Rheumatology, 31, 40-46.
[18]
Tishler, M., Yaron, I., Shirazi, I. and Yaron, M. (2001) Clinical and Immunological Characteristics of Elderly Onset Sjögren’s Syndrome: A Comparison with Younger Onset Disease. The Journal of Rheumatology, 28, 795-797.
[19]
Botsios, C., Furlan, A., Ostuni, P., Sfriso, P., Andretta, M., Ometto, F., et al. (2011) Elderly Onset of Primary Sjögren’s Syndrome: Clinical Manifestations, Serological Features and Oral/Ocular Diagnostic Tests-Comparison with Adult and Young Onset of the Disease in a Cohort of 336 Italian Patients. Joint Bone Spine, 78, 171-174. https://doi.org/10.1016/j.jbspin.2010.05.008
[20]
Lang, P.O. and Aspinall, R. (2012) Immunosenescence and Herd Immunity: With an Ever-Increasing Aging Population Do We Need to Rethink Vaccine Schedules? Expert Review of Vaccines, 11, 167-176. https://doi.org/10.1586/erv.11.187
[21]
Weiskopf, D., Weinberger, D. and Grubeck-Loebenstein, B. (2009) The Aging of the Immune System. Transplant International, 22, 1041-1050. https://doi.org/10.1111/j.1432-2277.2009.00927.x
[22]
Hallgren, H.M., Buckley, C.E., Gilbertsen, V.A. and Yunis, E.J. (1973) Lymphocyte Phytohemagglutinin Responsiveness Immunoglobulins and Autoantibodies in Aging Humans. The Journal of Immunology, 111, 1101-1107.
[23]
Moulias, R., Proust, J., Wang, A., Congy, F., Marescot, M.R., Deville Chabrolle, A., et al. (1984) Age-Related Increase in Autoantibodies. Lancet, 1, 1128-1129. https://doi.org/10.1016/s0140-6736(84)92547-9
[24]
Gordon, J. and Rosenthal, M. (1984) Failure to Detect Age-Related Increase of Non-Pathological Autoantibodies. Lancet, 323, 231. https://doi.org/10.1016/S0140-6736(84)92157-3
[25]
Franceschi, C., Monti, D., Sansoni, P. and Cossarizza, A. (1995) The Immunology of Exceptional Individuals: The Lesson of Centenarians. Immunology Today, 16, 12-16. https://doi.org/10.1016/0167-5699(95)80064-6
[26]
Rasch, E.K., Hirsch, R., Paulose-Ram, R. and Hochberg, M.C. (2003) Prevalence of Rheumatoid Arthritis in Persons 60 Years of Age and Older in the United States: Effect of Different Methods of Case Classification. Arthritis & Rheumatology, 48, 917-926. https://doi.org/10.1002/art.10897
[27]
Lopez-Hoyos, M., Ruiz De Alegria, C., Blanco, R., Crespo, J., Peña, M., Rodriguez-Valverde, V., et al. (2004) Clinical Utility or Anti-CCP Antibodies in the Differential Diagnosis of Elderly-Onset Rheumatoid Arthritis and Polymyalgia Rheumatic. Rheumatology, 43, 655-657. https://doi.org/10.1093/rheumatology/keh143
[28]
Cho, S.K., Sung, Y.K., Choi, C.B., Cha, H.S., Choe, J.Y., Chung, W.T., et al. (2012) Do Patients with Elderly Onset-Rheumatoid Arthritis Have Severe Functional Disability? Seminars in Arthritis and Rheumatism, 42, 23-31. https://doi.org/10.1016/j.semarthrit.2012.02.004
[29]
Haga, H.J. and Jonsson, R. (1999) The Influence of Age on Disease Manifestations and Serological Characteristics in Primary Sjögren’s Syndrome. Scandinavian Journal of Rheumatology, 28, 227-232. https://doi.org/10.1080/03009749950155599
[30]
Tutuncu, Z., Reed, G., Kremer, J. and Kavanaugh, A. (2006) Do Patients with Older-Onset Rheumatoid Arthritis Receive Less Aggressive Treatment? Annals of the Rheumatic Diseases, 65, 1226-1229. https://doi.org/10.1136/ard.2005.051144
[31]
Solomon, D.H., Yelin, E., Katz, J.N., Lu, B., Shaykevich, T. and Ayanian, J.Z. (2013) Treatment of Rheumatoid Arthritis in the Medicare Current Beneficiary Survey. Arthritis Research & Therapy, 15, Article No. R43. https://doi.org/10.1186/ar4201
[32]
Dixon, W.G., Abrahamowicz, M., Beauchamp, M.E., Ray, D.W., Bernatsky, S., Suissa, S., et al. (2012) Immediate and Delayed Impact of Oral Glucocorticoid Therapy on Risk of Serious Infection in Older Patients with Rheumatoid Arthritis: A Nested Case-Control Analysis. Annals of the Rheumatic Diseases, 71, 1128-1133. https://doi.org/10.1136/annrheumdis-2011-200702
